Merck & Company Inc (MRK)vsQuidel Corporation (QDEL)
MRK
Merck & Company Inc
$150.91
+0.94%
HEALTHCARE · Cap: $355.10B
QDEL
Quidel Corporation
$10.94
+0.74%
HEALTHCARE · Cap: $866.79M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 2389% more annual revenue ($66.57B vs $2.67B). MRK leads profitability with a 4.8% profit margin vs -39.2%. QDEL appears more attractively valued with a PEG of 2.06. QDEL earns a higher WallStSmart Score of 42/100 (D).
MRK
Hold36
out of 100
Grade: F
QDEL
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-77.2%
Fair Value
$83.04
Current Price
$150.91
$67.87 premium
Margin of Safety
+87.9%
Fair Value
$238.33
Current Price
$10.94
$227.39 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Reasonable price relative to book value
Areas to Watch
Trading at 8.9x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Expensive relative to growth rate
2.8% revenue growth
Smaller company, higher risk/reward
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : QDEL
The strongest argument for QDEL centers on Price/Book.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 116.1x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : QDEL
The primary concerns for QDEL are PEG Ratio, Revenue Growth, Market Cap. Debt-to-equity of 1.73 is elevated, increasing financial risk.
Key Dynamics to Monitor
MRK profiles as a value stock while QDEL is a turnaround play — different risk/reward profiles.
QDEL carries more volatility with a beta of 0.68 — expect wider price swings.
MRK is growing revenue faster at 5.1% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
QDEL scores higher overall (42/100 vs 36/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Quidel Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?